全文获取类型
收费全文 | 71128篇 |
免费 | 5982篇 |
国内免费 | 3264篇 |
专业分类
耳鼻咽喉 | 197篇 |
儿科学 | 1330篇 |
妇产科学 | 830篇 |
基础医学 | 12691篇 |
口腔科学 | 739篇 |
临床医学 | 5539篇 |
内科学 | 16739篇 |
皮肤病学 | 1073篇 |
神经病学 | 2650篇 |
特种医学 | 1293篇 |
外国民族医学 | 9篇 |
外科学 | 3881篇 |
综合类 | 10538篇 |
现状与发展 | 19篇 |
预防医学 | 6009篇 |
眼科学 | 486篇 |
药学 | 8835篇 |
18篇 | |
中国医学 | 3534篇 |
肿瘤学 | 3964篇 |
出版年
2023年 | 794篇 |
2022年 | 1853篇 |
2021年 | 2285篇 |
2020年 | 2148篇 |
2019年 | 2383篇 |
2018年 | 2273篇 |
2017年 | 2241篇 |
2016年 | 2603篇 |
2015年 | 2864篇 |
2014年 | 4654篇 |
2013年 | 4846篇 |
2012年 | 4778篇 |
2011年 | 5090篇 |
2010年 | 4121篇 |
2009年 | 3924篇 |
2008年 | 3874篇 |
2007年 | 3761篇 |
2006年 | 3429篇 |
2005年 | 2929篇 |
2004年 | 2425篇 |
2003年 | 2102篇 |
2002年 | 1710篇 |
2001年 | 1500篇 |
2000年 | 1156篇 |
1999年 | 1010篇 |
1998年 | 925篇 |
1997年 | 767篇 |
1996年 | 648篇 |
1995年 | 661篇 |
1994年 | 565篇 |
1993年 | 462篇 |
1992年 | 440篇 |
1991年 | 349篇 |
1990年 | 318篇 |
1989年 | 285篇 |
1988年 | 239篇 |
1987年 | 207篇 |
1986年 | 170篇 |
1985年 | 443篇 |
1984年 | 460篇 |
1983年 | 371篇 |
1982年 | 380篇 |
1981年 | 316篇 |
1980年 | 292篇 |
1979年 | 261篇 |
1978年 | 205篇 |
1977年 | 159篇 |
1976年 | 176篇 |
1975年 | 153篇 |
1974年 | 126篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Mirna SuČIĆ Dubravka Boban Mirjana MarkoviĆ-glamoČak Mladen PetroveČki Matko MaruŠIĆ Boris Labar 《Medical oncology (Northwood, London, England)》1992,9(1):41-45
Cytochemical analysis of leukemic blasts from 46 patients with acute myeloblastic M2 leukemia (according to the FAB classification)
was performed before and after cytostatic therapy, and compared with findings obtained in 20 age- and sex-matched control
subjects. Cytochemical findings for myeloperoxidase (MPO), Sudan black B, acid phosphatase and alpha-naphthyl-acetate esterase
(ANAE) were related to the achievement of the first complete remission (CR),i.e. data were compared after the patients had been divided into CR and non-CR groups. The analysis clearly showed that a high
proportion of myeloperoxidase- and, to a lesser extent, Sudan black B-positive blasts before treatment may have constituted
a significantly unfavourable prognostic factor. 相似文献
102.
本文对5105例乙肝三系统检测结果的32种组合形式出现率进行了统计分析,并引 入年龄因素分层分析。分析讨论了19岁以下、20~39岁、40~59岁及60岁以上四组受检者乙肝三系 统检测结果表现与分布的异同,并据此结合文献报道资料提出了预防处理意见。 相似文献
103.
P. A. Thürmann C. Sonnenburg-Chatzopoulos R. Lissner 《European journal of clinical pharmacology》1995,49(3):237-242
In two independent trials 10 and 12 healthy volunteers received the novel intravenous immunoglobulin (IVIG) preparations BT 511 and BT 507, respectively. BT 511 contains 5 g human plasma proteins per 100 ml, more than 95% of which are immunoglobulins of the G class (IgG). BT 507 contains in addition 61 IU antibody against hepatitis B surface antigen (anti-HBs)·ml–1. In trial I volunteers received 4.0 ml/kg (n+4) and 8.0 ml·kg–1 (n+6) BT 511 to study the tolerability and the magnitude of the increase in immunoglobulins in plasma as well as their decline over 1 month. After administration of the lower dose, plasma IgG increased from 10.7 to 14.7 g·l–1 directly after the infusion. Following the 8.0 ml·kg–1 dose a more pronounced increase from 12.4 to 21.2 g·l–1 was observed. No adverse events occurred. After 1 month IgG concentrations had almost reached baseline values at 12.2 g·l–1 in the 4.0 ml·kg–1 group, but were still significantly increased at 15.2 g·l–1 after the high dose. There was a linear correlation between the maximal IgG plasma concentration and the subsequent decline of IgG during the 29-day observation period. After administration of BT 507 maximal anti-HBs concentrations of 1778 mU·ml–1 occurred 1.4 h after termination of the infusion. The terminal elimination half-life was 22.4 days, and total clearance and volume of distribution were determined to be 0.122 ml·min–1 and 5.41, respectively. The pharmacokinetic parameters calculated for anti-HBs as an indicator of IgG were in accordance with the pharmacokinetic behaviour of native IgG. 相似文献
104.
105.
A panel of synthetic peptides representing human lymphocyte antigen (HLA) B8, other class I and class II restricted T cell epitopes and two B cell epitopes, were all able to compete with recognition of a HLA B8 restricted epitope by a cytotoxic T cell clone. Competition was obtained when the competitor peptides were added either before or after the target epitope. The target epitope also had a slow off rate, implicating allosteric inhibition. The presence of non-specific, allosteric binding sites may interfere with experiments attempting to define immunologically relevant MHC binding specificities. 相似文献
106.
Seishiro Hirano Takako Asami Naomi Kodama Kazuo T. Suzuki 《Archives of toxicology》1994,68(7):444-449
In a preceding study, we reported that the numbers of macrophages and polymorphonuclear leukocytes (PMN) were increased in
bronchoalveolar lavage fluid (BALF) following the intratracheal instillation of nickel sulfate (NiSO4) in rats. In the present study, BALF chemotactic activities for both macrophages and PMN were measured to investigate if
the increases of these inflammatory cells in BALF depend on increases in chemotactic activities in epithelial lining fluid
(ELF) of the lung. Both the number of PMN and the PMN chemotactic activity peaked at 2 days post-instillation and they were
significantly correlated. However, the PMN chemotactic activity was inversely correlated with concentration of leukotriene
B4 (LTB4), a well-known chemotaxin. Although PMN were not observed in control BALF, LTB4 concentration in the control ELF (ca. 5×10–7 M) was estimated to have a potential to attract PMN chemotactically through a membrane in in vitro migration assay. These
results suggest that the presence of LTB4 in ELF itself does not trigger transpulmonary PMN infiltration. The rat BALF were fractionated by high performance liquid
chromatography (HPLC), and PMN chemotactic activity of each fraction was measured. The elution profiles of PMN chemotactic
activity showed that there were at least two different chemotaxins in BALF obtained from the NiSO4-exposed rats. Macrophage chemotactic activity in BALF also peaked at 2 days post-instillation. However, the number of macrophages
was not significantly correlated with the chemotactic activity for macrophage in BALF. The HPLC study showed that the macrophage
chemotactic substance in the BALF obtained from NiSO4-exposed rats was different from complement fragment (C5a) and its MW was estimated to be 10 – 12 kD.
Received: 1 December 1993/Accepted: 16 March 1994 相似文献
107.
多重PCR归化法平行检测HBV和HCV的研究 总被引:3,自引:0,他引:3
目的:建立一种多重PCR归化法并应用于对HBV、HCV平行检测。方法:利用PCR反应5′端允许添加非互补序列的原理,运用内外两对引物,经过2轮扩增,使目的产物均带上共有序列,再以共有序列为引物进行扩增,实现多重扩增。比较和筛选四种核酸提取方法。运用正交优化法,优化并确定最佳扩增条件。对28份血标本进行对比试验,并进行质量评价。结果:归化多重PCR方法对于HBV、HCV病毒合并感染患者的诊断敏感性为83.5%,诊断特异性为70.0%,诊断指数为153.3%,诊断效率为72.2%;对HBsAg阳性患者的HBV DNA的诊断敏感性为78.6%,诊断特异性为80.0%,诊断指数为158.6%,诊断效率为79.2%。对抗-HCV阳性患者的HCV RNA的诊断敏感性为75.0%,诊断特异性为90.0%,诊断指数为165.0%,诊断效率为83.3%。结论:多重PCR归化法在多基因扩增或多种病原体的同时平行检测领域具有较大应用潜力。该方法实用、准确、可靠,对HBV HCV的防治具有实际意义。 相似文献
108.
冠心病患者血清同型半胱氨酸与叶酸、维生素B12水平的变化 总被引:6,自引:0,他引:6
目的 探讨冠心病患者血清同型半胱氨酸(HCY)与叶酸、维生素B12浓度的变化及其相关性。方法 选择84例经冠状动脉造影术证实为冠心病的患者,应用荧光偏振免疫分析法(FPIA)测定血清HCY浓度,离子捕获免疫分析法(ICIA)测定血清叶酸浓度,非均相微粒子酶免疫分析法(MEIA)测定血清维生素B12浓度。结果 冠心病患者血清HCY浓度增高,与正常对照组比较有显著性意义(P<0.001),而叶酸、维生素B12浓度则降低,与正常对照组比较有显著性意义(P<0.001),以上两种变化呈负相关(P<0.001)。结论 同型半胱氨酸血症是冠心病的新的独立危险因素,叶酸、维生素B12缺乏可能是诱发高HCY的重要因素。 相似文献
109.
目的 观察行为干预对慢性乙型肝炎患者健康行为的影响。方法 将300例慢性乙型肝炎患者作为目标人群进行健康教育,建立目标人群管理档案,进行目标人群健康行为干预,比较教育前后相关行为的改变。结果 慢性乙型肝炎患者8项健康行为和8项危险健康行为有明显改观,差异具有统计学意义(P〈0.01)。结论 通过行为干预,有效地使慢性乙型肝炎患者完全遵从医嘱合理用药,完全依从健康行为,从而减少危险行为的发生。 相似文献
110.
SHIGEKI OCHI MORIKAZU ONJI KAZUHITO SHIRAISHI KYOKO OHTU TOMOHIRO AKAO YOSHITO YANO NOBUYUKI TAKEI HIKARU MATSUI YASUYUKI OHTA MASAKICHI UMEDA 《Journal of gastroenterology and hepatology》1991,6(6):599-602
To clarify the prevalence of concurrent infection with hepatitis C virus (HCV), hepatitis B virus (HBV) and human T cell leukaemia virus (HTLV), we measured HCV antibody in the population of a district endemic for HBV and HTLV infection. Blood samples were collected in June 1990 from 579 inhabitants of four islands of Uwa Bay in the southwest of Ehime Prefecture in Japan. Anti-HCV antibody against C100-3 protein was detected using an enzyme-linked immunosorbent assay kit (Ortho Diagnostics). Thirteen of the 579 inhabitants (2.2%) were positive for anti-HCV, and this prevalence rate was not significantly different from the frequency of anti-HCV in Tokyo blood donors. A total of 11% (64 of 579) of the subjects were positive for HBsAg and 3.3% (19 of 579) were positive for anti-HTLV. These frequencies of HBsAg and anti-HTLV positivity were distinctly higher than the respective means of Japanese. All anti-HCV positive individuals were negative for HBsAg and anti-HTLV, while 54% (7 of 13) had increased alanine aminotransferase levels. These data suggest that the prevalence of HCV infection is not high even in an area endemic for HBV and HTLV infection. 相似文献